Goldman Sachs has led a $62 million Series D round of financing in Fountain Medical Development Limited, a Chinese clinical-stage contract research organization (CRO) offering one-stop services to pharmaceutical and medical device companies.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
